Bericht
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
This Research Paper is a contribution to the debate and reform process of the WHO to enable it to respond to the health and health policy challenges of the twenty-first century. More specifically, this paper addresses the issue of the pharmaceutical innovation system within the perspective of access to medicines, exploring possible structural changes in the current system. To do so, it addresses the question of how the constitutional powers of the WHO, often ignored by the Organization itself, can contribute positively to a paradigm shift in biomedical research stimulation.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 42
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Velásquez, Germán
Seuba, Xavier
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2011
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Velásquez, Germán
- Seuba, Xavier
- South Centre
Entstanden
- 2011
Ähnliche Objekte (12)
Rethinking policy options for export earnings
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Pharmaceutical innovation, incremental patenting and compulsory licensing
The right to health in pharmaceutical patent disputes
Re-thinking global and local manufacturing of medical products after COVID-19
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Patent protection for plants: Legal options for developing countries
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Rethinking policy options for export earnings
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Pharmaceutical innovation, incremental patenting and compulsory licensing
The right to health in pharmaceutical patent disputes
Re-thinking global and local manufacturing of medical products after COVID-19
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Patent protection for plants: Legal options for developing countries
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Rethinking policy options for export earnings
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Pharmaceutical innovation, incremental patenting and compulsory licensing
The right to health in pharmaceutical patent disputes
Re-thinking global and local manufacturing of medical products after COVID-19
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Patent protection for plants: Legal options for developing countries
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community